Executive Summary
Nufarm Limited, together with its subsidiaries, manufactures and sells crop protection products in Australia, New Zealand, Asia, Europe, North America, and South America.
Snowflake
Fundamentals
Moderate growth potential with questionable track record.
Similar Companies
Share Price & News
How has Nufarm's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NUF's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
2.5%
NUF
1.6%
AU Chemicals
1.2%
AU Market
1 Year Return
6.7%
NUF
11.8%
AU Chemicals
12.1%
AU Market
Return vs Industry: NUF underperformed the Australian Chemicals industry which returned 11.8% over the past year.
Return vs Market: NUF underperformed the Australian Market which returned 12.1% over the past year.
Shareholder returns
| NUF | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.5% | 1.6% | 1.2% |
| 30 Day | -3.7% | 5.1% | 2.0% |
| 90 Day | 36.8% | 13.1% | 3.2% |
| 1 Year | 6.7%6.7% | 13.2%11.8% | 18.3%12.1% |
| 3 Year | -21.6%-26.7% | 27.1%19.1% | 40.6%22.1% |
| 5 Year | 39.8%27.3% | 50.0%28.9% | 54.2%19.8% |
Price Volatility Vs. Market
How volatile is Nufarm's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall St
Why Nufarm Limited (ASX:NUF) Could Be Worth Watching2 weeks ago | Simply Wall St
Does Nufarm Limited's (ASX:NUF) CEO Pay Compare Well With Peers?4 weeks ago | Simply Wall St
Estimating The Fair Value Of Nufarm Limited (ASX:NUF)Valuation
Is Nufarm undervalued compared to its fair value and its price relative to the market?
84.23x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: NUF (A$6.24) is trading above our estimate of fair value (A$5.48)
Significantly Below Fair Value: NUF is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: NUF is poor value based on its PE Ratio (84.2x) compared to the Chemicals industry average (43.7x).
PE vs Market: NUF is poor value based on its PE Ratio (84.2x) compared to the Australian market (18.6x).
Price to Earnings Growth Ratio
PEG Ratio: NUF is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: NUF is good value based on its PB Ratio (1.1x) compared to the AU Chemicals industry average (4.6x).
Next Steps
Future Growth
How is Nufarm forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
37.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NUF's forecast earnings growth (37.9% per year) is above the savings rate (2.3%).
Earnings vs Market: NUF's earnings (37.9% per year) are forecast to grow faster than the Australian market (9.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NUF's revenue (0.2% per year) is forecast to grow slower than the Australian market (3.6% per year).
High Growth Revenue: NUF's revenue (0.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NUF's Return on Equity is forecast to be low in 3 years time (6.2%).
Next Steps
Past Performance
How has Nufarm performed over the past 5 years?
-1.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NUF has high quality earnings.
Growing Profit Margin: NUF's current net profit margins (0.7%) are higher than last year (-0.8%).
Past Earnings Growth Analysis
Earnings Trend: NUF's earnings have declined by -1.9% per year over the past 5 years.
Accelerating Growth: NUF has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: NUF has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-0.02%).
Return on Equity
High ROE: NUF's Return on Equity (1.6%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Nufarm's financial position?
Financial Position Analysis
Short Term Liabilities: NUF's short term assets (A$3.2B) exceeds its short term liabilities (A$1.8B)
Long Term Liabilities: NUF's short term assets (3.2B) exceeds its long term liabilities (1.5B)
Debt to Equity History and Analysis
Debt Level: NUF's debt to equity ratio (72.3%) is considered high
Reducing Debt: NUF's debt to equity ratio has increased from 47.7% to 72.3% over the past 5 years.
Debt Coverage: NUF's debt is not well covered by operating cash flow (5.6%).
Interest Coverage: NUF's interest payments on its debt are not well covered by EBIT (1.8x coverage).
Balance Sheet
Inventory Level: NUF has a high level of physical assets or inventory.
Debt Coverage by Assets: NUF's debt is covered by short term assets (assets are 1.9x debt).
Next Steps
Dividend
What is Nufarm's current dividend yield, its reliability and sustainability?
1.88%
Forecast Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate NUF's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate NUF's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NUF's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NUF's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: NUF is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NUF's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
Next Steps
Management
What is the CEO of Nufarm's salary, the management and board of directors tenure and is there insider trading?
3.0yrs
Average management tenure
CEO
Greg Hunt (60yo)
4.5yrs
Tenure
AU$1,763,052
Compensation
Mr. Gregory Allan Hunt, also known as Greg, Grad. Dip., Mgmnt, AMP Harvard, AICD, REBA, has been the Chief Executive Officer and Managing Director of Nufarm Limited since May 05, 2015. Mr. Hunt serves as MÂ ...
CEO Compensation Analysis
Compensation vs Market: Greg's total compensation ($USD1.21M) is about average for companies of similar size in the Australian market ($USD1.41M).
Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.
Management Age and Tenure
3.0yrs
Average Tenure
Experienced Management: NUF's management team is considered experienced (3 years average tenure).
Board Age and Tenure
7.6yrs
Average Tenure
63yo
Average Age
Experienced Board: NUF's board of directors are considered experienced (7.6 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Company |
| Shares | 512 |
| Max Price | AU$6.17 |
| Entity | Company |
| Shares | 17,759 |
| Max Price | AU$6.32 |
| Entity | Company |
| Shares | 9,415 |
| Max Price | AU$6.29 |
| Entity | Company |
| Shares | 268,033 |
| Max Price | AU$6.42 |
| Entity | Company |
| Shares | 11,303 |
| Max Price | AU$6.30 |
| Entity | Company |
| Shares | 512 |
| Max Price | AU$6.17 |
| Entity | Company |
| Shares | 292,531 |
| Max Price | AU$6.33 |
| Entity | Company |
| Shares | 71,148 |
| Max Price | AU$6.70 |
| Entity | Company |
| Shares | 49,341 |
| Max Price | AU$6.60 |
| Entity | Company |
| Shares | 70,943 |
| Max Price | AU$6.71 |
| Entity | Company |
| Shares | 35,845 |
| Max Price | AU$6.64 |
| Entity | Company |
| Shares | 328,187 |
| Max Price | AU$6.76 |
| Entity | Company |
| Shares | 1,353,117 |
| Max Price | AU$6.75 |
| Entity | Company |
| Shares | 267,270 |
| Max Price | AU$6.75 |
| Entity | Company |
| Shares | 4,759 |
| Max Price | AU$4.70 |
| Entity | Company |
| Shares | 222,485 |
| Max Price | AU$6.56 |
| Entity | Company |
| Shares | 563,326 |
| Max Price | AU$6.71 |
| Entity | Company |
| Shares | 2,878,329 |
| Max Price | AU$6.25 |
| Entity | Company |
| Shares | 2,524,829 |
| Max Price | AU$4.05 |
| Entity | Company |
| Shares | 6,692,470 |
| Max Price | AU$4.88 |
| Entity | Company |
| Shares | 15,008,939 |
| Max Price | AU$5.72 |
| Entity | Company |
| Shares | 444,118 |
| Max Price | AU$4.11 |
| Entity | Company |
| Shares | 5,787,069 |
| Max Price | AU$4.92 |
| Entity | Company |
| Shares | 4,101,725 |
| Max Price | AU$4.25 |
| Entity | Company |
| Shares | 542,525 |
| Max Price | AU$4.60 |
| Entity | Company |
| Shares | 144,701 |
| Max Price | AU$4.58 |
| Entity | Company |
| Shares | 370,140 |
| Max Price | AU$4.57 |
| Entity | Company |
| Shares | 43,825 |
| Max Price | AU$4.52 |
| Entity | Company |
| Shares | 28 |
| Max Price | AU$4.41 |
| Entity | Company |
| Shares | 28 |
| Max Price | AU$4.41 |
| Entity | Company |
| Shares | 53,254 |
| Max Price | AU$4.22 |
| Entity | Company |
| Shares | 466,988 |
| Max Price | AU$4.23 |
| Entity | Company |
| Shares | 4,734,010 |
| Max Price | AU$4.54 |
| Entity | Individual |
| Role | Member of the Board of Directors Non-Executive Independent Director |
| Shares | 11,400 |
| Max Price | AU$4.12 |
| Entity | Individual |
| Role | Member of the Board of Directors Non-Executive Independent Director |
| Shares | 11,400 |
| Max Price | AU$4.12 |
| Entity | Company |
| Shares | 4,205 |
| Max Price | AU$5.29 |
| Entity | Company |
| Shares | 2,211,223 |
| Max Price | AU$5.46 |
| Entity | Company |
| Shares | 108,118 |
| Max Price | AU$4.56 |
| Entity | Company |
| Shares | 4,205 |
| Max Price | AU$5.29 |
| Entity | Company |
| Shares | 3,005,987 |
| Max Price | AU$5.50 |
| Entity | Company |
| Shares | 2,923,696 |
| Max Price | AU$5.50 |
| Entity | Company |
| Shares | 513,224 |
| Max Price | AU$5.46 |
| Entity | Company |
| Shares | 7,030,877 |
| Max Price | AU$4.90 |
| Entity | Company |
| Shares | 5,166,742 |
| Max Price | AU$4.77 |
| Entity | Company |
| Shares | 14,620,101 |
| Max Price | AU$4.89 |
| Entity | Company |
| Shares | 2,992,800 |
| Max Price | AU$6.18 |
| Entity | Company |
| Shares | 7,851,042 |
| Max Price | AU$5.45 |
| Entity | Company |
| Shares | 5,076,069 |
| Max Price | AU$4.67 |
| Entity | Company |
| Shares | 14,092,464 |
| Max Price | AU$6.26 |
| Entity | Company |
| Shares | 144,934 |
| Max Price | AU$4.45 |
| Entity | Company |
| Shares | 104,602 |
| Max Price | AU$4.50 |
| Entity | Company |
| Shares | 11,855 |
| Max Price | AU$4.50 |
| Entity | Company |
| Shares | 20,893 |
| Max Price | AU$4.47 |
| Entity | Company |
| Shares | 221,836 |
| Max Price | AU$4.50 |
| Entity | Individual |
| Role | Member of the Board of Directors Non-Executive Independent Director |
| Shares | 18,095 |
| Max Price | AU$4.62 |
| Entity | Company |
| Shares | 58,437 |
| Max Price | AU$5.36 |
| Entity | Company |
| Shares | 162,002 |
| Max Price | AU$6.50 |
| Entity | Company |
| Shares | 80,055 |
| Max Price | AU$6.11 |
| Entity | Company |
| Shares | 2,126,983 |
| Max Price | AU$6.56 |
| Entity | Company |
| Shares | 226,891 |
| Max Price | AU$6.54 |
| Entity | Company |
| Shares | 2,795,691 |
| Max Price | AU$6.55 |
| Entity | Company |
| Shares | 226,891 |
| Max Price | AU$6.54 |
| Entity | Company |
| Shares | 2,648,958 |
| Max Price | AU$6.58 |
| Entity | Individual |
| Role | Chief Executive Officer MD, CEO & Executive Director |
| Shares | 23,500 |
| Max Price | AU$4.27 |
| Entity | Individual |
| Role | Member of the Board of Directors Non-Executive Independent Director |
| Shares | 15,000 |
| Max Price | AU$4.47 |
| Entity | Company |
| Shares | 2,342,067 |
| Max Price | AU$5.61 |
| Entity | Company |
| Shares | 4,154,140 |
| Max Price | AU$6.28 |
| Entity | Company |
| Shares | 42,423 |
| Max Price | AU$5.77 |
| Entity | Company |
| Shares | 155,819 |
| Max Price | AU$6.11 |
| Entity | Company |
| Shares | 65,789 |
| Max Price | AU$6.01 |
| Entity | Company |
| Shares | 6,423,507 |
| Max Price | AU$6.09 |
| Entity | Company |
| Shares | 2,991,389 |
| Max Price | AU$5.71 |
| Entity | Company |
| Shares | 361,210 |
| Max Price | AU$6.07 |
| Entity | Company |
| Shares | 310,973 |
| Max Price | AU$6.08 |
| Entity | Company |
| Shares | 320,016 |
| Max Price | AU$6.47 |
| Entity | Company |
| Shares | 521,805 |
| Max Price | AU$6.02 |
| Entity | Company |
| Shares | 16,593 |
| Max Price | AU$6.08 |
| Entity | Company |
| Shares | 80,243 |
| Max Price | AU$6.15 |
| Entity | Company |
| Shares | 3,272 |
| Max Price | AU$6.13 |
| Entity | Company |
| Shares | 337,837 |
| Max Price | AU$6.09 |
| Entity | Company |
| Shares | 560,808 |
| Max Price | AU$6.15 |
| Entity | Company |
| Shares | 14,850 |
| Max Price | AU$5.91 |
| Entity | Company |
| Shares | 764,133 |
| Max Price | AU$7.56 |
| Entity | Company |
| Shares | 956,430 |
| Max Price | AU$7.56 |
| Entity | Company |
| Shares | 14,850 |
| Max Price | AU$5.91 |
| Entity | Company |
| Shares | 365,001 |
| Max Price | AU$7.11 |
| Entity | Company |
| Shares | 1,229,211 |
| Max Price | AU$7.54 |
| Entity | Company |
| Shares | 13,082,569 |
| Max Price | AU$5.87 |
| Entity | Company |
| Shares | 987,339 |
| Max Price | AU$5.88 |
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.9%.
Management Team
Fiona Smith
Group Executive Corporate Services
- Tenure: 0.4yrs
Paul Binfield (54yo)
Chief Financial Officer
- Tenure: 8yrs
- Compensation: AU$1.07m
Greg Hunt (60yo)
MD, CEO & Executive Director
- Tenure: 4.5yrs
- Compensation: AU$1.76m
Brent Zacharias
Group Executive of Nuseed
- Tenure: 4.3yrs
- Compensation: AU$909.82k
Nerida Mossop
General Manager of Investor Relations & Corporate Communications
- Tenure: 0.8yrs
John Holding
Group Executive of People & Performance
- Tenure: 1.8yrs
Board Members
Donald McGauchie (69yo)
Non-Executive Independent Chairman
- Tenure: 9.3yrs
- Compensation: AU$392.57k
Peter Margin (59yo)
Non-Executive Independent Director
- Tenure: 8.1yrs
- Compensation: AU$203.76k
Greg Hunt (60yo)
MD, CEO & Executive Director
- Tenure: 4.5yrs
- Compensation: AU$1.76m
Anne Brennan (59yo)
Non-Executive Independent Director
- Tenure: 8.8yrs
- Compensation: AU$190.27k
Gordon Davis (63yo)
Non-Executive Independent Director
- Tenure: 8.5yrs
- Compensation: AU$209.15k
Frank Ford (73yo)
Non-Executive Independent Director
- Tenure: 7.1yrs
- Compensation: AU$197.82k
Toshikazu Takasaki (72yo)
Non-Independent Non-Executive Director
- Tenure: 6.9yrs
- Compensation: AU$170.04k
Marie McDonald (63yo)
Non-Executive Independent Director
- Tenure: 2.7yrs
- Compensation: AU$186.22k
Company Information
Nufarm Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Nufarm Limited
- Ticker: NUF
- Exchange: ASX
- Founded: 2000
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Market Cap: AU$2.369b
- Shares outstanding: 379.64m
- Website: https://www.nufarm.com
Number of Employees
Location
- Nufarm Limited
- 103-105 Pipe Road
- Laverton North
- Victoria
- 3026
- Australia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| NUF | ASX (Australian Securities Exchange) | Yes | Ordinary Shares | AU | AUD | Jan 1992 |
| NUFM.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Jan 1992 |
| NUF | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Jan 1992 |
| NUF | CHIA (Chi-X Australia) | Yes | Ordinary Shares | AU | AUD | Jan 1992 |
| NFRM.Y | OTCPK (Pink Sheets LLC) | SPONSORED ADR | US | USD | Jan 2016 |
Biography
Nufarm Limited, together with its subsidiaries, manufactures and sells crop protection products in Australia, New Zealand, Asia, Europe, North America, and South America. It operates through two segments, Â ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/11/12 10:31 |
| End of Day Share Price | 2019/11/12 00:00 |
| Earnings | 2019/07/31 |
| Annual Earnings | 2019/07/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.